The more things change, the more they stay the same, or so the saying goes. Seems apt when looking ahead to the big stories looming in 2015 for imaging.
Digital breast tomosynthesis scored a win on Oct. 31, 2014, when the Centers for Medicare and Medicaid Services (CMS) approved Medicare reimbursement for women undergoing a tomosynthesis exam in conjunction with 2D digital mammography.
The arrival of the Ebola virus in the U.S. last year caught at least one medical facility off guard and has prompted officials to rethink response protocols when it comes to the highly fatal, infectious disease.
Digital radiography has now largely replaced film across the U.S., making workflows more efficient and offering more sophisticated image processing and storage.
When the calendar flipped to 2015, a number of changes occurred with Medicare’s Physician Quality Reporting System (PQRS) program, with the headline being the disappearance of incentive payments.
Over the past several years, studies involving theranostic nanoparticles have provided several shining examples of where molecular cancer imaging is going.
